QRG Capital Management Inc. lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 105,663 shares of the company's stock after purchasing an additional 4,423 shares during the quarter. QRG Capital Management Inc.'s holdings in HCA Healthcare were worth $31,715,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Proficio Capital Partners LLC boosted its position in HCA Healthcare by 43,546.1% during the fourth quarter. Proficio Capital Partners LLC now owns 223,468 shares of the company's stock worth $67,074,000 after purchasing an additional 222,956 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its position in shares of HCA Healthcare by 3.1% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 4,209 shares of the company's stock valued at $1,263,000 after acquiring an additional 125 shares during the last quarter. Mn Services Vermogensbeheer B.V. increased its holdings in shares of HCA Healthcare by 1.9% during the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 78,900 shares of the company's stock worth $23,682,000 after buying an additional 1,500 shares during the last quarter. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $31,000. Finally, National Pension Service boosted its stake in HCA Healthcare by 3.6% during the fourth quarter. National Pension Service now owns 570,291 shares of the company's stock worth $171,173,000 after buying an additional 19,637 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
HCA has been the topic of a number of recent research reports. Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. StockNews.com cut HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. Raymond James downgraded shares of HCA Healthcare from an "outperform" rating to a "market perform" rating in a research report on Friday, November 22nd. Royal Bank of Canada cut their price target on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. Finally, Barclays cut their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $385.67.
Get Our Latest Stock Report on HCA
HCA Healthcare Stock Performance
Shares of HCA stock traded up $4.81 during trading on Monday, reaching $311.11. The company had a trading volume of 1,410,262 shares, compared to its average volume of 1,731,794. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The firm's 50 day simple moving average is $315.15 and its two-hundred day simple moving average is $349.23. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market capitalization of $77.26 billion, a PE ratio of 14.16, a PEG ratio of 1.10 and a beta of 1.64.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the company earned $5.90 earnings per share. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.93%. HCA Healthcare's payout ratio is currently 13.11%.
Insider Activity at HCA Healthcare
In other news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by company insiders.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.